Your browser doesn't support javascript.
loading
Diagnostic and therapeutic recommendations in adult dystonia: a joint document by the Italian Society of Neurology, the Italian Academy for the Study of Parkinson's Disease and Movement Disorders, and the Italian Network on Botulinum Toxin.
Romano, Marcello; Bagnato, Sergio; Altavista, Maria Concetta; Avanzino, Laura; Belvisi, Daniele; Bologna, Matteo; Bono, Francesco; Carecchio, Miryam; Castagna, Anna; Ceravolo, Roberto; Conte, Antonella; Cosentino, Giuseppe; Eleopra, Roberto; Ercoli, Tommaso; Esposito, Marcello; Fabbrini, Giovanni; Ferrazzano, Gina; Lalli, Stefania; Mascia, Marcello Maria; Osio, Maurizio; Pellicciari, Roberta; Petrucci, Simona; Valente, Enza Maria; Valentino, Francesca; Zappia, Mario; Zibetti, Maurizio; Girlanda, Paolo; Tinazzi, Michele; Defazio, Giovanni; Berardelli, Alfredo.
Afiliação
  • Romano M; Neurology and Stroke Unit, Villa Sofia Cervello Hospital, Palermo, Italy.
  • Bagnato S; Unit of Neurophysiology and Unit for Severe Acquired Brain Injuries, Rehabilitation Department, Giuseppe Giglio Foundation, Cefalù, Italy.
  • Altavista MC; Neurology Unit, San Filippo Neri Hospital ASL, Italian Network on Botulinum Toxin (RITB SIN), Rome, Italy.
  • Avanzino L; Department of Experimental Medicine, Human Physiology Section, University of Genoa, IRCCS San Martino Polyclinic, Genoa, Italy.
  • Belvisi D; IRCCS San Martino Polyclinic, Genoa, Italy.
  • Bologna M; Department of Human Neurosciences, Sapienza University of Rome, Viale dell' Università 30, 00185, Rome, Italy.
  • Bono F; IRCCS Neuromed, Pozzilli, IS, Italy.
  • Carecchio M; Department of Human Neurosciences, Sapienza University of Rome, Viale dell' Università 30, 00185, Rome, Italy.
  • Castagna A; IRCCS Neuromed, Pozzilli, IS, Italy.
  • Ceravolo R; Botulinum Toxin Center, Neurology Unit, Mater Domini University Hospital, Italian Network On Botulinum Toxin (RITB SIN), Catanzaro, Italy.
  • Conte A; Parkinson and Movement Disorders Unit, Study Center On Neurodegeneration (CESNE), Department of Neuroscience, University of Padua, Padua, Italy.
  • Cosentino G; IRCCS Fondazione Don Carlo Gnocchi Onlus, Milan, Italy.
  • Eleopra R; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Ercoli T; Department of Human Neurosciences, Sapienza University of Rome, Viale dell' Università 30, 00185, Rome, Italy.
  • Esposito M; IRCCS Neuromed, Pozzilli, IS, Italy.
  • Fabbrini G; Department of Brain and Behavioral Sciences, University of Pavia, IRCCS Mondino Foundation, Pavia, Italy.
  • Ferrazzano G; Parkinson and Movement Disorders Unit, Department of Clinical Neuroscience, IRCCS Foundation Carlo Besta Neurological Institute, Milan, Italy.
  • Lalli S; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
  • Mascia MM; U.O.C. of Neurophysiology, A.O.R.N. A. Cardarelli, Naples, Italy.
  • Osio M; Department of Human Neurosciences, Sapienza University of Rome, Viale dell' Università 30, 00185, Rome, Italy.
  • Pellicciari R; IRCCS Neuromed, Pozzilli, IS, Italy.
  • Petrucci S; Department of Human Neurosciences, Sapienza University of Rome, Viale dell' Università 30, 00185, Rome, Italy.
  • Valente EM; Department of Neurology, IRCCS Humanitas Research Hospital, via Manzoni 56, 20089, Rozzano, Milan, Italy.
  • Valentino F; Institute of Neurology, Azienda Ospedaliero Universitaria Di Cagliari, SS 554 km 4.500, 09042, Cagliari, Italy.
  • Zappia M; Department of Neurology, Luigi Sacco Hospital, University of Milan, Milan, Italy.
  • Zibetti M; Department of Basic Science, Neuroscience, and Sensory Organs, University Aldo Moro, Bari, Italy.
  • Girlanda P; Department of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy.
  • Tinazzi M; Medical Genetics and Advanced Cell Diagnostics Unit, S, Andrea University Hospital, Rome, Italy.
  • Defazio G; Neurogenetics Research Center, IRCCS Mondino Foundation, Pavia, Italy.
  • Berardelli A; Department of Molecular Medicine, University of Pavia, Pavia, Italy.
Neurol Sci ; 43(12): 6929-6945, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36190683
The diagnostic framework and the therapeutic management of patients with adult dystonia can represent a challenge for clinical neurologists. The objective of the present paper is to delineate diagnostic and therapeutic recommendations for dystonia provided by a panel of Italian experts afferent to the Italian Society of Neurology, the Italian Academy for the Study of Parkinson's Disease and Movement Disorders, and the Italian Network on Botulinum Toxin. We first discuss the clinical approach and the instrumental assessment useful for diagnostic purpose. Then, we analyze the pharmacological, surgical, and rehabilitative therapeutic options for adult dystonia. Finally, we propose a hospital-territory network model for adult dystonia management.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Toxinas Botulínicas / Distúrbios Distônicos / Distonia / Neurologia Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Adult / Humans Idioma: En Revista: Neurol Sci Assunto da revista: NEUROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Toxinas Botulínicas / Distúrbios Distônicos / Distonia / Neurologia Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Adult / Humans Idioma: En Revista: Neurol Sci Assunto da revista: NEUROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália